Resistance Exercise Training For Improved Muscle Insulin Sensitivity
Overview
Tab Title Description
Study type
InterventionalDescribes the nature of a clinical study. Types include:
- Observational study — observes people and measures outcomes without affecting results.
- Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices.
- Medical records research — uses historical information collected from medical records of large groups of people to study how diseases progress and which treatments and surgeries work best.
Study IDs
Site IRB
- Rochester, Minnesota: 24-011544
Sponsor Protocol Number: 24-011544
About this study
The purpose of this research is to uncover the underlying mechanisms of resistance exercise training benefits on glucose metabolism and insulin sensitivity in muscle.
Participation eligibility
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.
Inclusion Criteria:
Exclusion criteria:
The presence of any of the following is an exclusion for the study:
Active coronary artery disease or heart failure.
Participation in a structured exercise program > 1 day/week.
A known medical condition that in the judgment of the investigator might interfere with the completion
Of the protocol such as the following examples:
Abnormal liver function test results (Transaminase >2 times the upper limit of normal)
Abnormal renal function test results (calculated GFR <60 mL/min/1.73m2
If on antihypertensive, thyroid, anti-depressant or lipid lowering medication, lack of stability on the medication for the past 2 months prior to enrollment in the study
Uncontrolled thyroid disease (TSH undetectable or >10 mlU/L); testing required within three months prior to admission for subjects with a goiter, positive antibodies, or who are on thyroid hormone replacement, and within one year otherwise
Abuse of alcohol or recreational drugs
Active tobacco usage
Infectious process not anticipated to resolve prior to study procedures (e.g. meningitis, pneumonia, osteomyelitis).
Uncontrolled arterial hypertension (Resting diastolic blood pressure >90 mmHg and/or systolic blood pressure >160 mmHg) at the time of screening
A recent injury to body or limb, muscular disorder, use of any medication, any carcinogenic disease, or other significant medical disorder if that injury, medication or disease in the judgment of the investigator will affect the completion of the protocol
Active pregnancy
Menopause (defined as absence of menstruation for 12 consecutive months)
Restrictions on Use of Other Drugs or Treatments:
Note: Other protocol defined Inclusion/Exclusion Criteria may apply.
Eligibility last updated 11/22/2024. Questions regarding updates should be directed to the study team contact.
Participating Mayo Clinic locations
Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.
| Mayo Clinic Location |
Status |
|
Rochester, Minn.
Mayo Clinic principal investigator Mark Pataky, Ph.D., M.S. |
Contact us for the latest status |
|
More information
Publications
Publications are currently not available